Associated Press: More Details about FDA Warning Strattera Associated with Suicide Thu, 29 Sep 2005 On April 26, 2004, we wrote: “The Alliance for Human Research Protection is concerned that children who are prescribed the failed antidepressant, Strattera, may be exposed to undisclosed serious risks of harm. FDA’s-approved label states:…
TIME – Medicating Young Minds with Mood / Behavior Altering Drugs Sat, 1 Nov 2003 A TIME magazine cover story (excerpt below) looks at the inordinate popularity of prescribing mood altering psychotropic drugs for children begins to raise troubling questions about the specter of doing long-term harm to children. Doctors…
A growing Crisis: Aggressive Marketing of drugs for children_Lou Dobbs-CNN Fri, 3 Oct 2003 CNN’s anchor Lou Dobbs, an astute business journalist whose program Lou Dobbs Tonight on CNN examines politics, the economy and a broad range of issues that affect the quality of life and standard of living of…
Comments submitted by The Alliance for Human Research Protection Re: Best Pharmaceuticals for Children’s Act of 2002 The National Academy of Sciences Committee of the Institute of Medicine on Clinical Research Involving Children August 18, 2003 Vera Hassner Sharav, President John H. Noble, Jr., Ph.D, Treasurer David Cohen, Ph.D, Secretary…
AHRP has been closely monitoring pediatric research trends since passage of the FDA Modernization Act of 1997. We believe that medications used in children should be thoroughly tested for safety, effectiveness and appropriate dose. But unlike adults who can exercise their autonomous right to informed consent, children who are enrolled in clinical trials are non-consensual human subjects. They should not, therefore, be made to assume the burden of testing possibly toxic drugs whose safety is unknown.
References for THE IMPACT OF THE FDA MODERNIZATION ACT ON THE RECRUITMENT OF CHILDREN FOR RESEARCH Vera Hassner Sharav Published in ETHICAL HUMAN SCIENCES & SERVICES Summer 2003, vol. 5 pp. 83-108 Agency for Health Care Research & Quality. (1999). Treatment of attention-deficit/hyperactivity disorder: Summary, evidence Report / Technology assessment…
MassHealth: Children overwhelmed with Psychiatric Drugs_Globe Sun, 9 Mar 2003 The Boston Globe reports that the top official for health and human services in Massachusetts plans to take action to stem the abusive “haphazard” prescribing of psychiatric drugs for children: “The use of stimulants, antidepressants, and antipsychotics among children has…
Infomail Archive – Pre 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav December 28, 2002: Will 2 to 5 year old Amer. kids be exposed to Smallpox Vaccine? Israeli Intelligence says “No immediate threat” December 24, 2002: Moral turpitude: Herpes experiment surpasses Tuskegee December 20,…
NY Times Preschool Meds December 15, 2002 How, one wonders, do the editors of The New York Times Magazine define what’s “fit to print”? Does bias toward promoting increased drug use while avoiding disclosure of conflicts of interest enter the editors’ decision-making process? Below is a letter to the editor…
November 08, 2002 Investigative series finds kids drugged without cause – Journal News The Journal News, a regional NYS newspaper conducted a three month investigation of residential treatment centers (RTC) for troubled children in NYS. The findings reported in a 7-part investigative series show “a pattern of increasing use” of…
Ritalin Outrage: Congress_ Big Media Under the Influence of Big Drugs September 30, 2002 Two hard hitting editorials–one by Nicholas Regush of Redflagsweekly.com. the other by Tony DiGirolamo of CutureShockTV.com focus on the scorge of Ritalin and the victimization of millions of children who are pushed to becoming addicted to…
Subject: NY Post Prompts Cong Hearings re: Children prescribed Ritalin Date: Wed, 25 Sep 2002 14:23:26 -0400 An investigative series by the New York Post re: the pressure brought to bear on parents to medicate their normal children with psychostimulant drugs–despite the risk of addiction and other serious adverse reactions–…
